Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Adam-Stokes Attacks

glucose, (beta-d)-isomer has been researched along with Adam-Stokes Attacks in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
George, JT; Hantel, S; Koitka-Weber, A; Levin, A; Perkovic, V; von Eynatten, M; Wanner, C; Wheeler, DC	1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Adam-Stokes Attacks

Article	Year
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Clinical journal of the American Society of Nephrology : CJASN, 2020, 10-07, Volume: 15, Issue:10 Topics: Adams-Stokes Syndrome; Aged; Albuminuria; Benzhydryl Compounds; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Infections; Male; Middle Aged; Mortality; Myocardial Infarction; Placebos; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors	2020

Article

Year

Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories:

Clinical journal of the American Society of Nephrology : CJASN, 2020, 10-07, Volume: 15, Issue:10

Topics: Adams-Stokes Syndrome; Aged; Albuminuria; Benzhydryl Compounds; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Infections; Male; Middle Aged; Mortality; Myocardial Infarction; Placebos; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors

2020